Cubist pharmaceuticals stock
WebStock Information. Stock Quote & Chart; Historic Stock Lookup; Investment Calculator; Analyst Coverage; Earnings Estimates; Debt Information; Dividend History; Ownership … WebA. ANTIVENIN™ (LATRODECTUS MACTANS) B. BCG Vaccine (For Percutaneous Use) BELSOMRA® (suvorexant) tablets, for oral use, C-IV. BRIDION® (sugammadex) Injection, for intravenous use. C. CANCIDAS® (caspofungin acetate) for Injection, for intravenous use. CUBICIN® (daptomycin for injection) for Intravenous Use.
Cubist pharmaceuticals stock
Did you know?
WebMar 23, 2024 · CUBIST PHARMACEUTICALS INC (NASDAQ:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CUBIST PHARMACEUTICALS INC Nasdaq: Nasdaq cubist pharmaceuticals inc Add to my list End-of-day quote Nasdaq - 09:24 2024 … CUBIST PHARMACEUTICALS INC : News, information and stories for CUBIST … CUBIST PHARMACEUTICALS INC : Company profile, business summary, … WebApr 11, 2024 · 11 brokerages have issued 1-year price targets for Madrigal Pharmaceuticals' stock. Their MDGL share price forecasts range from $151.00 to $390.00. On average, they expect the company's stock price to reach $294.75 in the next twelve months. This suggests a possible upside of 21.7% from the stock's current price.
WebDec 8, 2014 · Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the companies have entered into a definitive agreement under which Merck will acquire … WebThis Stock Option Agreement (the “Agreement”) governs an award (the “Award”) of stock options (“Stock Options”) to non-employee members of the Board of Directors of Cubist Pharmaceuticals, Inc. (the “Company”) who have been selected for participation (each such director, a “Participant”) under the Company’s 2014 Omnibus ...
WebApr 11, 2024 · 12 analysts have issued 1 year price objectives for Xenon Pharmaceuticals' stock. Their XENE share price forecasts range from $45.00 to $60.00. On average, they anticipate the company's share price to reach $50.70 in the next year. This suggests a possible upside of 50.2% from the stock's current price. View analysts price targets for … WebCubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. …
WebApr 12, 2024 · Cubist Systematic Strategies LLC now owns 334,168 shares of the biopharmaceutical company’s stock valued at $4,662,000 after purchasing an additional 261,412 shares during the period.
WebApr 10, 2024 · 10 analysts have issued 1 year price objectives for Ionis Pharmaceuticals' stock. Their IONS share price forecasts range from $27.00 to $67.00. On average, they predict the company's share price to reach $45.17 in the next year. This suggests a possible upside of 21.2% from the stock's current price. View analysts price targets for IONS or … games about not giving upWebApr 12, 2024 · Cubist Systematic Strategies LLC now owns 334,168 shares of the biopharmaceutical company’s stock valued at $4,662,000 after buying an additional 261,412 shares during the period. Hedge funds... games about obedienceWeb467037 (CBST) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed 467037 (CBST) YHD - YHD Delayed Price. Currency in USD Follow - (-) At close: … games about nervous systemWebApr 11, 2024 · In other Enanta Pharmaceuticals news, CEO Jay R. Luly sold 27,912 shares of the firm’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $45.16, for a total ... black friday holidays dealsWebFind the latest 467037 (CBST) stock quote, history, news and other vital information to help you with your stock trading and investing. black friday holy weekWebAccess our live streaming chart for the Cubist Pharmaceuticals Inc stock, free of charge. games about nutritionWebSep 5, 2013 · Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced the pricing of $700 million aggregate principal amount of convertible senior unsecured notes that will be issued in two series, with one series of $300 million aggregate principal amount maturing on September 1, 2024 (the 2024 notes) and the other series of $400 million aggregate … games about numbers